Jin Zhu-Qiu, Goetzl Edward J, Karliner Joel S
Cardiology Section, VA Medical Center and Department of Medicine, University of California, San Francisco, USA.
Circulation. 2004 Oct 5;110(14):1980-9. doi: 10.1161/01.CIR.0000143632.06471.93. Epub 2004 Sep 27.
Phosphorylation of sphingosine by sphingosine kinase (SK) is the rate-limiting step in the cellular synthesis of sphingosine 1-phosphate (S1P). The monoganglioside GM1, which stimulates SK, is cardioprotective in part through increased generation of S1P that protects myocytes by diverse mechanisms. Because protein kinase C (PKC)epsilon activation is necessary for myocardial ischemic preconditioning (IPC) and PKC activators increase SK activity, we tested the hypothesis that SK may be a central mediator of IPC.
In adult murine hearts, IPC sufficient to reduce infarct size significantly increased cardiac SK activity, induced translocation of SK protein from the cytosol to membranes, and enhanced cardiac myocyte survival. IPC did not increase SK activity in PKCepsilon-null mice. The SK antagonist N,N-dimethylsphingosine inhibited PKCepsilon activation and directly abolished the protective effects of IPC and the enhanced SK activity induced by IPC.
These findings demonstrate that PKCepsilon is thus recruited by IPC and induces activation of SK that then mediates IPC-induced cardioprotection in murine heart.
鞘氨醇激酶(SK)催化鞘氨醇磷酸化是细胞合成1-磷酸鞘氨醇(S1P)的限速步骤。单唾液酸四己糖神经节苷脂GM1可刺激SK,其心脏保护作用部分是通过增加S1P生成实现的,S1P通过多种机制保护心肌细胞。由于蛋白激酶C(PKC)ε激活是心肌缺血预处理(IPC)所必需的,且PKC激活剂可增加SK活性,因此我们检验了SK可能是IPC核心介质这一假说。
在成年小鼠心脏中,足以减小梗死面积的IPC可显著增加心脏SK活性,诱导SK蛋白从胞质溶胶转位至细胞膜,并增强心肌细胞存活能力。在PKCε基因敲除小鼠中,IPC并未增加SK活性。SK拮抗剂N,N-二甲基鞘氨醇可抑制PKCε激活,并直接消除IPC的保护作用以及IPC诱导的SK活性增强。
这些发现表明,IPC可募集PKCε并诱导SK激活,并由此介导IPC诱导的小鼠心脏保护作用。